ReviewTherapeutic advances in infectious disease

Ensitrelvir as a novel treatment option for mild-to-moderate COVID-19: a narrative literature review.

Hiroshi Mukae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.